98%
921
2 minutes
20
Introduction: The aim of this study was to evaluate the safety and effectiveness of fixing dislocated intraocular lenses (IOLs) with Gore-Tex suture scleral fixation, compared to IOL explantation combined with a secondary implant using a standardized flanged intrascleral fixation (Yamane technique).
Methods: The study included patients that underwent rescue of a dislocated single-piece, four-eyelet acrylic IOL, fixated to the sclera with Gore-Tex sutures (group A), or IOL explantation followed by three-piece IOL implant using the Yamane technique (group B).
Primary Outcomes: uncorrected and best corrected distance visual acuity (UCDVA and BCDVA), refractive target, corneal cylinder (CC), endothelial cell loss (ECL), and postoperative complications.
Results: Thirty-four eyes (group A, 16; group B, 18) of 34 consecutive patients were included. Overall mean follow-up was 11.4 ± 2.2 months. In both groups, UCDVA and BCDVA significantly improved (p < 0.001) at last visit. Final refractive target and CC were not significantly different between the groups (p = 0.62). ECL was significantly greater (p = 0.001) in group B (14.7%; -306 ± 11 cells/mm2) than in A (5.1%; -105.6 ± 12 cells/mm2).
Conclusions: The rescue approach with Gore-Tex suture scleral fixation was similar to IOL explantation combined with Yamane technique regarding functional and refractive outcomes. A lesser degree of ECL occurred after the rescue approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000546898 | DOI Listing |
Prehosp Emerg Care
September 2025
Albuquerque Fire Rescue, PO Box 1293, Albuquerque NM 87103.
Cardiac arrest response and management is a critical piece of prehospital clinical practice yet the majority of these patients do not survive to be transported. Termination of resuscitation and resulting death notification is stressful and emotional for both loved ones and EMS clinicians. We describe a fundamental shift from traditional termination of resuscitation to a patient and family-centered model.
View Article and Find Full Text PDFElife
September 2025
Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, United States.
The microglial surface protein Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) plays a critical role in mediating brain homeostasis and inflammatory responses in Alzheimer's disease (AD). The soluble form of TREM2 (sTREM2) exhibits neuroprotective effects in AD, though the underlying mechanisms remain elusive. Moreover, differences in ligand binding between TREM2 and sTREM2, which have major implications for their roles in AD pathology, remain unexplained.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
Department of Neurosciences, Institute of Human Anatomy, University of Padova, 35121 Padova, Italy.
Harlequin syndrome, also known as differential hypoxia (DH) or North-South syndrome, is a serious complication of femoro-femoral venoarterial extracorporeal membrane oxygenation (V-A ECMO). Moreover, Harlequin syndrome is caused by competing flows between the retrograde oxygenated ECMO output and the anterograde ejection of poorly oxygenated blood from the native heart. In the setting of impaired pulmonary gas exchange, the addition of an Impella device (ECPELLA configuration), although beneficial for ventricular unloading and hemodynamic support, may further exacerbate this competition and precipitate DH.
View Article and Find Full Text PDFCureus
August 2025
Department of Orthopaedic Surgery, King George's Medical University, Lucknow, IND.
Introduction Proximal femoral fractures are a major cause of disability, particularly in aging populations, with an increasing incidence. Although osteosynthesis remains the first-line treatment, failures are common due to various complications. Total hip arthroplasty (THA) is the preferred salvage procedure in such cases, despite its technical challenges.
View Article and Find Full Text PDFJCI Insight
September 2025
Edinburgh Medical School: Biomedical Sciences & Euan MacDonald Centre for M, University of Edinburgh, Edinburgh, United Kingdom.
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein. Several therapeutic approaches boosting SMN are approved for human patients, delivering remarkable improvements in lifespan and symptoms. However, emerging phenotypes, including neurodevelopmental comorbidities, are being reported in some treated SMA patients, indicative of alterations in brain development.
View Article and Find Full Text PDF